<i>NEJM Evidence</i> — A New Journal in the NEJM Group Family
Chana A. Sacks(Harvard University), Eric Rubin, Jeffrey M. Drazen(Brigham and Women's Hospital), Neil Galloway, C. Corey Hardin(Massachusetts General Hospital), Sharon‐Lise T. Normand(Harvard University), Rebekah Linga, Patrick M. Hannon, Siri Kadire(University of North Carolina Health Care), Kate Takvorian
Cited by 0
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
|Journal of Allergy and Clinical Immunology|2010|746
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
|Journal of Clinical Investigation|1997|336